The Leadership Team at Catalym spearheads the company's strategic direction and operational excellence, overseeing aspects from preclinical research and regulatory affairs to clinical operations and financial management. This cohesive unit ensures the effective development and translation of innovative antibody therapies targeting placental factors in various tumors, driving the company's mission forward.
View all